Research and Markets: Cholesterol Monitoring: Self- and Near-Testing Creating Opportunities

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/4f6417/cholesterol_monito) has
announced the addition of the "Cholesterol Monitoring: Self- and Near-Testing
Creating Opportunities" report to their offering.

Cholesterol Monitoring: Near- and Self-Testing Creating Opportunities is a
comprehensive evaluation and analysis of the devices and companies shaping this
dynamic segment of the cardiovascular health management sector.

Published in March (2007), the study is designed to provide pharmaceutical
companies, diagnostics developers, device marketers, and supply chain
participants with a detailed understanding of the economics, technologies,
products, and potential for cholesterol self-testing and near-patient
monitoring, and to identify business opportunities for market participants.
Provider organization business managers, healthcare administrators and investors
can also benefit from this study.

Demographics, Health Initiatives and Patient Awareness In spite of numerous
healthcare initiatives, coronary heart disease (CHD) and stroke continue to be
leading causes of mortality and morbidity in most industrialized countries.
According to the U.S. Center for Disease Control, 12.9 million people suffer
from CHD in the U.S. alone.

Current efforts to reduce the impact of coronary heart disease and stroke focus
on the identification of genetic and environmental risk factors, patient
education, and monitoring cholesterol levels. The vast majority of cholesterol
testing is now performed in laboratories based on samples taken in physician
offices or similar healthcare settings. But this will change. The convergence of
improved technologies, patient demographics and managed care cost initiatives
will drive a shift in cholesterol testing from laboratories and toward the
point-of-care and patient homes.

For self-testing, the key enabler of this shift will be technological advances
that will provide accurate readings in a format that consumers can understand,
clearly indicating when a follow-up visit to a caregiver is needed. Systems that
allow patients to share readings with physicians electronically have already
been introduced. Ultimately, the success of this self-test market will rely on
monitors that can provide accurate values for the various classes of lipids that
are associated with cardiovascular risk, presenting them to the patient in the
proper context.

Forecasts and projections cover the period from 2007 to 2010.

Feature Summary

* Analyzes and evaluates self-test and near-patient cholesterol monitoring
technologies and products, and assesses the market potential for existing and
probable future products
* Examines potential next-generation cholesterol monitor technologies, design
issues and market factors
* Provides risk and opportunity assessments for self-test and near-patient
cholesterol testing
* Forecasts the influence of cholesterol monitoring on the cardiovascular
healthcare management market
* Profiles cholesterol self-testing market participants, their product
development activity, and strategies
* Evaluates the impact of economic, technology, and regulatory factors on
cholesterol testing products and companies

Key Topics Covered:

* Executive Summary
* Cholesterol Management Market Dynamics
* Cholesterol Testing Market Segments
* Cholesterol Measurement Technology Factors
* FDA-Approved Product Assessments and Analysis
* Market & Product Life Cycle Factors
* Company Profiles

For more information visit
http://www.researchandmarkets.com/research/4f6417/cholesterol_monito

Research and Markets
Laura Wood, Senior Manager, press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Copyright Business Wire 2009